Acrivon Therapeutics, Inc. — 8-K Filings
40 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 40 8-K documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-115139 | Mar 19, 2026 | — |
| 8-K | 8-K | 0001193125-26-085516 | Mar 2, 2026 | Feb 25, 2026 |
| 8-K | 8-K | 0001193125-26-079500 | Feb 27, 2026 | — |
| 8-K | 8-K | 0001193125-26-007077 | Jan 8, 2026 | — |
| 8-K | 8-K | 0001193125-26-007007 | Jan 8, 2026 | — |
| 8-K | 8-K | 0001193125-25-280172 | Nov 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-197250 | Sep 5, 2025 | — |
| 8-K | 8-K | 0001193125-25-179834 | Aug 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-086246 | Jun 13, 2025 | — |
| 8-K | 8-K | 0000950170-25-071385 | May 14, 2025 | — |
| 8-K | 8-K | 0000950170-25-051576 | Apr 7, 2025 | — |
| 8-K | 8-K | 0000950170-25-046163 | Mar 27, 2025 | — |
| 8-K | 8-K | 0000950170-25-044549 | Mar 25, 2025 | — |
| 8-K | 8-K | 0000950170-25-039520 | Mar 14, 2025 | Mar 11, 2025 |
| 8-K | 8-K | 0000950170-24-125920 | Nov 13, 2024 | — |
| 8-K | 8-K | 0000950170-24-114213 | Oct 11, 2024 | — |
| 8-K | 8-K | 0001193125-24-219180 | Sep 16, 2024 | Sep 14, 2024 |
| 8-K | 8-K | 0000950170-24-095766 | Aug 13, 2024 | — |
| 8-K | 8-K | 0000950170-24-075760 | Jun 21, 2024 | Jun 20, 2024 |
| 8-K | 8-K | 0000950170-24-059097 | May 14, 2024 | — |
| 8-K | 8-K | 0000950170-24-047560 | Apr 24, 2024 | — |
| 8-K | 8-K | 0000950170-24-042789 | Apr 9, 2024 | Apr 8, 2024 |
| 8-K | 8-K | 0000950170-24-037627 | Mar 28, 2024 | — |
| 8-K | 8-K | 0001193125-24-056937 | Mar 4, 2024 | — |
| 8-K | 8-K | 0001193125-24-027629 | Feb 8, 2024 | Feb 7, 2024 |
| 8-K | 8-K | 0001193125-24-003885 | Jan 8, 2024 | — |
| 8-K | 8-K | 0001193125-23-291705 | Dec 8, 2023 | Dec 4, 2023 |
| 8-K | 8-K | 0001193125-23-274124 | Nov 9, 2023 | — |
| 8-K | 8-K | 0001193125-23-228639 | Sep 5, 2023 | — |
| 8-K | 8-K | 0001193125-23-209745 | Aug 11, 2023 | — |
| 8-K | 8-K | 0000950170-23-029447 | Jun 22, 2023 | — |
| 8-K | 8-K | 0001193125-23-160789 | Jun 5, 2023 | May 30, 2023 |
| 8-K | 8-K | 0001193125-23-138948 | May 9, 2023 | — |
| 8-K | 8-K | 0001193125-23-129712 | May 1, 2023 | — |
| 8-K | 8-K | 0001193125-23-128896 | May 1, 2023 | — |
| 8-K | 8-K | 0001193125-23-114750 | Apr 25, 2023 | — |
| 8-K | 8-K | 0001193125-23-081445 | Mar 28, 2023 | — |
| 8-K | 8-K | 0001193125-23-068545 | Mar 13, 2023 | — |
| 8-K | 8-K | 0001193125-23-060173 | Mar 3, 2023 | — |
| 8-K | 8-K | 0001193125-22-287727 | Nov 17, 2022 | Nov 14, 2022 |